{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:56:38Z","timestamp":1769601398955,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"crossref","award":["2014CB542300"],"award-info":[{"award-number":["2014CB542300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Major Research Plan Training Program of China","award":["91339108"],"award-info":[{"award-number":["91339108"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370362"],"award-info":[{"award-number":["81370362"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81273599"],"award-info":[{"award-number":["81273599"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81170246"],"award-info":[{"award-number":["81170246"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Municipal Education Commission-Gaofeng Clinical Medicine","award":["20152509"],"award-info":[{"award-number":["20152509"]}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research (CIHR)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Heart & Stroke Foundation"},{"name":"GYO and Scientific Research Project of Health Bureau of Shanghai","award":["201440368"],"award-info":[{"award-number":["201440368"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.peptides.2016.10.005","type":"journal-article","created":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T02:32:49Z","timestamp":1477017169000},"page":"85-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Ascending aortic adventitial remodeling and fibrosis are ameliorated with Apelin-13 in rats after TAC via suppression of the miRNA-122 and LGR4-\u03b2-catenin signaling"],"prefix":"10.1016","volume":"86","author":[{"given":"Ran","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen-Zhou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lai-Jiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Min","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Jie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Le","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin Y.","family":"Oudit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Rui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ding-Liang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiu-Chang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2016.10.005_bib0005","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/cge.12713","article-title":"The genetics and pathogenesis of thoracic aortic aneurysm disorder and dissections","volume":"89","author":"Zhang","year":"2016","journal-title":"Clin. Genet."},{"key":"10.1016\/j.peptides.2016.10.005_bib0010","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1161\/ATVBAHA.113.301624","article-title":"Aortic remodeling after transverse aortic constriction in mice is attenuated with AT1 receptor blockade","volume":"33","author":"Kuang","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.peptides.2016.10.005_bib0015","doi-asserted-by":"crossref","first-page":"H1329","DOI":"10.1152\/ajpheart.01341.2008","article-title":"Apelin prevents aortic aneurysm formation by inhibiting macrophage inflammation","volume":"296","author":"Leeper","year":"2009","journal-title":"Am. J. Physiol. Heart. Circ. Physiol."},{"issue":"Suppl. 1","key":"10.1016\/j.peptides.2016.10.005_bib0020","doi-asserted-by":"crossref","first-page":"e403","DOI":"10.1097\/01.hjh.0000501036.54612.96","article-title":"OS 36-07 Treatment with Apelin-13 prevents pressure overload-induced aortic adventitial remodeling and fibrosis in hypertensive rats with TAC","volume":"34","author":"Zhong","year":"2016","journal-title":"J. Hypertens."},{"key":"10.1016\/j.peptides.2016.10.005_bib0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/hr.2013.110","article-title":"The interaction of transient receptor potential melastatin 7 with macrophages promotes vascular adventitial remodeling in transverse aortic constriction rats","volume":"37","author":"Li","year":"2014","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.peptides.2016.10.005_bib0030","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.peptides.2013.05.006","article-title":"Post-infarct treatment with [Pyr1]-apelin-13 reduces myocardial damage through reduction of oxidative injury and nitric oxide enhancement in the rat model of myocardial infarction","volume":"46","author":"Azizi","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2016.10.005_bib0035","first-page":"3343","article-title":"Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis","volume":"118","author":"Chun","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.peptides.2016.10.005_bib0040","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1172\/JCI69608","article-title":"Apelin is a positive regulator of ACE2 in failing hearts","volume":"123","author":"Sato","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.peptides.2016.10.005_bib0045","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1006\/bbrc.1998.9489","article-title":"Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor","volume":"251","author":"Tatemoto","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.peptides.2016.10.005_bib0050","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejphar.2015.04.034","article-title":"Post-infarct treatment with [Pyr(1)]apelin-13 improves myocardial function by increasing neovascularization and overexpression of angiogenic growth factors in rats","volume":"761","author":"Azizi","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.peptides.2016.10.005_bib0055","doi-asserted-by":"crossref","first-page":"148","DOI":"10.5152\/balkanmedj.2011.036","article-title":"The effects of apelin on mesenteric ischemia and reperfusion damage in an experimental rat mode","author":"Sa\u011f\u0131ro\u011flu","year":"2012","journal-title":"Balkan. Med. J."},{"key":"10.1016\/j.peptides.2016.10.005_bib0060","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/ncb2867","article-title":"Ablation of LGR4 promotes energy expenditure by driving white-to-brown fat switch","volume":"15","author":"Wang","year":"2013","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.peptides.2016.10.005_bib0065","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fendo.2015.00131","article-title":"LGR4 and its role in intestinal protection and energy metabolism","volume":"6","author":"Li","year":"2015","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.peptides.2016.10.005_bib0070","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1042\/CS20130538","article-title":"microRNA-122 down-regulation may play a role in severe myocardial fibrosis in human aortic stenosis through TGF-\u03b21 up-regulation","volume":"126","author":"Beaumont","year":"2014","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.peptides.2016.10.005_bib0075","first-page":"16014","article-title":"Circulating miR-122-5p as a potential novel biomarker for diagnosis of acute myocardial infarction","volume":"8","author":"Yao","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.peptides.2016.10.005_bib0080","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.3892\/mmr.2013.1691","article-title":"Efficient delivery of miR-122 to regulate cholesterol metabolism using a non-covalent peptide-based strategy","volume":"8","author":"Wang","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.peptides.2016.10.005_bib0085","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12967-015-0616-8","article-title":"Deletion of angiotensin-converting enzyme 2 exacerbates renal inflammation and injury in apolipoprotein E-deficient mice through modulation of the nephrin and TNF-alpha-TNFRSF1A signaling","volume":"13","author":"Jin","year":"2015","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.peptides.2016.10.005_bib0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.peptides.2016.03.008","article-title":"Angiotensin-converting enzyme 2 ameliorates renal fibrosis by blocking the activation of mTOR\/ERK signaling in apolipoprotein E-deficient mice","volume":"79","author":"Chen","year":"2016","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2016.10.005_bib0095","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1253\/circj.CJ-13-0805","article-title":"Loss of angiotensin-converting enzyme 2 exacerbates myocardial injury via activation of the CTGF-fractalkine signaling pathway","volume":"77","author":"Song","year":"2013","journal-title":"Circ. J."},{"key":"10.1016\/j.peptides.2016.10.005_bib0100","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/CIRCULATIONAHA.110.955369","article-title":"Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction","volume":"122","author":"Zhong","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2016.10.005_bib0105","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11906-008-0020-3","article-title":"The role of the renin-angiotensin system in aortic aneurysmal diseases","volume":"10","author":"Lu","year":"2008","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.peptides.2016.10.005_bib0110","first-page":"1426","article-title":"Angiotensin II is related to the acute aortic dissection complicated with lung injury through mediating the release of MMP9 from macrophages","volume":"8","author":"Wu","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.peptides.2016.10.005_bib0115","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/HYPERTENSIONAHA.114.03388","article-title":"Angiotensin-converting enzyme 2 is a critical determinant of angiotensin II-induced loss of vascular smooth muscle cells and adverse vascular remodeling","volume":"64","author":"Patel","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2016.10.005_bib0120","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.peptides.2014.11.001","article-title":"The protective effect of apelin on ischemia\/reperfusion injury","volume":"63","author":"Yang","year":"2015","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2016.10.005_bib0125","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/1479-5876-11-229","article-title":"Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice","volume":"11","author":"Zhang","year":"2013","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.peptides.2016.10.005_bib0130","doi-asserted-by":"crossref","first-page":"C6","DOI":"10.1016\/j.jacc.2014.06.040","article-title":"Apelin treatment enhances ACE2 expression and attenuates angiotensin II-mediated aortic fibrosis in apolipoprotein E-deficient mice","volume":"64","author":"Zhang","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.peptides.2016.10.005_bib0135","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/HJH.0b013e32834347de","article-title":"Apelin protects against angiotensin II-induced cardiovascular fibrosis and decreases plasminogen activator inhibitor type-1 production","volume":"29","author":"Siddiquee","year":"2011","journal-title":"J. Hypertens."},{"key":"10.1016\/j.peptides.2016.10.005_bib0140","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.cardiores.2007.02.002","article-title":"Apelin modulates aortic vascular tone via endothelial nitric oxide synthase phosphorylation pathway in diabetic mice","volume":"74","author":"Zhong","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.peptides.2016.10.005_bib0145","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/j.1476-5381.2012.02192.x","article-title":"The apelin receptor inhibits the angiotensin II type 1 receptor via allosteric trans-inhibition","volume":"168","author":"Siddiquee","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.peptides.2016.10.005_bib0150","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/hr.2011.19","article-title":"Non-activated APJ suppresses the angiotensin II type 1 receptor, whereas apelin-activated APJ acts conversely","volume":"34","author":"Sun","year":"2011","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.peptides.2016.10.005_bib0155","doi-asserted-by":"crossref","first-page":"e000249","DOI":"10.1161\/JAHA.113.000249","article-title":"Loss of Apelin exacerbates myocardial infarction adverse remodeling and ischemia-reperfusion injury: therapeutic potential of synthetic Apelin analogues","volume":"2","author":"Wang","year":"2013","journal-title":"J. Am. Heart. Assoc."},{"key":"10.1016\/j.peptides.2016.10.005_bib0160","doi-asserted-by":"crossref","first-page":"11452","DOI":"10.1073\/pnas.1106083108","article-title":"R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt\/beta-catenin signaling","volume":"108","author":"Carmon","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.peptides.2016.10.005_bib0165","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/jcmm.12754","article-title":"MicroRNA-503 promotes angiotensin II-induced cardiac fibrosis by targeting Apelin-13","volume":"20","author":"Zhou","year":"2016","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.peptides.2016.10.005_bib0170","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1161\/ATVBAHA.111.232165","article-title":"Nuclear factor of activated T cells 5 regulates vascular smooth muscle cell phenotypic modulation","volume":"31","author":"Halterman","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978116302054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978116302054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T07:56:19Z","timestamp":1589702179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978116302054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":34,"alternative-id":["S0196978116302054"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2016.10.005","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ascending aortic adventitial remodeling and fibrosis are ameliorated with Apelin-13 in rats after TAC via suppression of the miRNA-122 and LGR4-\u03b2-catenin signaling","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2016.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}